Le Lézard
Classified in: Health
Subjects: MAV, EXE, VET

Media Advisory - Minister of Veterans Affairs to Attend the 2017 Canadian Military and Veteran Health Research Forum


TORONTO, Sept. 25, 2017 /CNW/ - The Honourable Seamus O'Regan, Minister of Veterans Affairs and Associate Minister of National Defence, will address participants during the eighth annual Canadian Military and Veteran Health Research Forum, organized by the Canadian Institute for Military and Veteran Health Research.

Each year, this forum brings together hundreds of leading Canadian and international researchers to discuss issues relating to military and Veteran well-being, including health.

 

Location:

105 Princes' Blvd, Toronto, ON M6K 3C3



Date:

September 26, 2017



Time:

9:00a.m.

 

SOURCE Veterans Affairs Canada


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: